Shorter radiation treatment for high-risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether a shorter course of radiation works as well as the usual longer course for people with high-risk prostate cancer. The goal is to keep cancer control while possibly reducing treatment time and inconvenience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed prostate cancer called adenocarcinoma (from biopsy or other cell test)
- Your prostate cancer is “high-risk,” based on at least one of these: stage T3a/T3b (not T4), PSA over 20 (with special PSA rules if you used finasteride/dutasteride), Gleason score 8–10, or pelvic lymph node involvement on imaging
- Your prostate size is under 100 cubic centimeters before hormone treatment starts
- No signs of spread to bones or other organs beyond the pelvic lymph nodes (a special PET scan can be used instead of some imaging tests)
- You cannot have had prior prostate radiation in the area being treated, and you cannot have had prostate removal surgery or prostate spot-killing procedures
- You must be able to have prostate MRI for treatment planning, and your health status is acceptable (ECOG 0–2)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests proton radiation therapy for people with high-risk prostate cancer. It may help by delivering radiation in a more targeted way, with the goal of controlling the cancer while reducing exposure to nearby healthy tissue.
This trial tests whether giving a short course of hormone therapy (apalutamide) along with targeted, high-dose radiation (SBRT) is safe and effective for men with a specific type of intermediate-risk prostate cancer. You may benefit if you fit the exact risk and test criteria.
This trial tests a precise radiation technique that adapts to your body's daily changes. It may offer better outcomes for men with prostate cancer that hasn't spread outside the pelvic area.
This trial tests a type of radiation that adapts to your body's changes during treatment. It is for men with low- to intermediate-risk prostate cancer that hasn't spread.
This trial compares two types of radiation therapy for prostate cancer that has come back or spread to a few places after surgery. The goal is to see which radiation schedule works better with fewer side effects.
This trial tests a shorter radiation plan using an MRI machine to guide treatment. The goal is to see if two high-dose sessions work just as well as longer treatment, with fewer side effects. It is for men with low or intermediate risk prostate cancer.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.